RNA Dysregulation: An Expanding Source of Cancer Immunotherapy Targets is a research paper published in Trends in Pharmacological Sciences (2021). On theSindex it has a DataRank of 0. It has been cited 60 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Cancer Institute
Grant: P50CA092131
National Cancer Institute
Grant: R01CA220238
National Cancer Institute
Grant: U01CA233074
National Cancer Institute
Grant: U24CA232979
Parker Institute for Cancer Immunotherapy
Grant: 20163828
NCI NIH HHS
Grant: U24 CA274159
NCI NIH HHS
Grant: R01 CA222695
National Institutes of Health
FWCI
3.85
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Additional file 1 of Downregulation of HNRNPA1 induced neoantigen generation via regulating alternative splicing
Additional file 1 of Downregulation of HNRNPA1 induced neoantigen generation via regulating alternative splicing